SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
62 hedge funds and large institutions have $99.5M invested in Sorrento Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
–
Holders Change %
0%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
16
Reduced
20
Closed
7
Calls
$730K
Puts
$181K
Net Calls
+$549K
Net Calls Change
+$387K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.27M |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.24M |
3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$562K |
4 |
UBS Group
Zurich,
Switzerland
|
+$262K |
5 |
HighTower Advisors
Chicago,
Illinois
|
+$228K |